Target intelligence / Profile preview

RNA, U6 small nuclear 1240, pseudogene (RNU6-1240P)

Target
RNU6-1240P
Molecular classification
Other (pseudogene, small nuclear RNA pseudogene, non-coding RNA pseudogene)
01

Overview

RNA, U6 small nuclear 1240, pseudogene (RNU6-1240P) is a human genomic locus classified as a pseudogene, specifically deriving from U6 small nuclear RNA (snRNA)[1][5]. Pseudogenes are genomic DNA sequences similar to normal genes but are nonfunctional; they arise from gene duplication or retrotransposition events and typically lack the ability to encode a functional product[2]. U6 snRNA pseudogenes, including RNU6-1240P, are distributed widely in mammalian genomes and predominantly result from LINE-1 (L1)-mediated retrotransposition, which is a process that copies RNA molecules back into DNA and inserts them at new genomic locations[2]. These U6 snRNA-derived pseudogenes do not produce functional RNAs or proteins and have no documented role as biological receptors, enzymes, or signaling molecules. They are not known therapeutic targets and have no established role in disease, biomarker development, or drug interaction[1][2][5]. RNU6-1240P is best described as a non-functional pseudogene copy of a small nuclear RNA gene, lacking recognized biological, clinical, or pharmacological relevance.

Other names
RNU6-1240P
02

Mechanism of action

None

03

Biological functions

None (pseudogene; no documented biological function)
04

Disease associations

None (no evidence implicating in disease)

Beyond the preview

Go deeper on RNA, U6 small nuclear 1240, pseudogene (RNU6-1240P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 1240, pseudogene (RNU6-1240P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call